Biotricity, Inc.
BTCY
$0.52
-$0.0099-1.87%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.62M | 3.27M | 3.20M | 3.18M | 2.97M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.62M | 3.27M | 3.20M | 3.18M | 2.97M |
| Cost of Revenue | 855.10K | 807.70K | 838.60K | 906.00K | 805.00K |
| Gross Profit | 2.76M | 2.46M | 2.36M | 2.27M | 2.17M |
| SG&A Expenses | 2.38M | 2.25M | 2.97M | 4.61M | 3.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.79M | 3.57M | 4.32M | 6.22M | 4.25M |
| Operating Income | -169.00K | -307.70K | -1.12M | -3.04M | -1.28M |
| Income Before Tax | -1.23M | -1.56M | -3.69M | -4.18M | -2.81M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.23M | -1.56M | -3.69M | -4.18M | -2.81M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.23M | -1.56M | -3.69M | -4.18M | -2.81M |
| EBIT | -169.00K | -307.70K | -1.12M | -3.04M | -1.28M |
| EBITDA | -167.50K | -306.20K | -1.12M | -3.04M | -1.28M |
| EPS Basic | -0.05 | -0.07 | -0.49 | -0.47 | -0.34 |
| Normalized Basic EPS | -0.03 | -0.04 | -0.15 | -0.38 | -0.20 |
| EPS Diluted | -0.05 | -0.07 | -0.49 | -0.47 | -0.34 |
| Normalized Diluted EPS | -0.03 | -0.04 | -0.15 | -0.38 | -0.20 |
| Average Basic Shares Outstanding | 24.23M | 22.49M | 14.17M | 9.44M | 8.98M |
| Average Diluted Shares Outstanding | 24.23M | 22.49M | 14.17M | 9.44M | 8.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.48% | -0.39% | -0.32% | 0.00% | -0.22% |
